Reunion Neuroscience News and Activities

Reunion Neuroscience is a company listed under the stock ticker REUN (US).

Acquisition, funding and merger involving Reunion Neuroscience.

• Reunion Neuroscience has just announced a $103 Million fundraising (posted on August 8 2025).

View the org chart displaying its 13 main executives

Most searched biographies at Reunion Neuroscience

• Sahil Kirpekar, President, Chief Executive Officer
• Ellen Lubman, Board Member
• Michael Ehlers, Director

Popular executive movements at Reunion Neuroscience

• Greg Mayes, President and Chief Executive Officer, has left the company  (posted on June 16 2026).
• Sahil Kirpekar has joined the company as President, Chief Executive Officer  (posted on June 16 2026).

Create your alert
to follow the executive moves at Reunion Neuroscience.

Reunion Neuroscience has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Reunion Neuroscience

Social media about Reunion Neuroscience

• Reunion Neuroscience on Wikipedia, Google News & Yahoo Finance
• Reunion Neuroscience on LinkedIn, X (Twitter) & YouTube